David McWilliams

the way people dress, but also the way people look and their weight, right?

Now, the problem with Ozempic and Monjaro is they're expensive, right?

Ozempic, for example, costs $5 to make, package, and deliver, right?

Okay.

But those people without insurance in the United States pay $1,300 a month

are $15,600 a year to actually take these drugs.

They're incredibly expensive, right?

So originally, these are anti-diabetic drugs.

If you're diabetes, if your doctor says you have diabetes, you can get these on health insurance.

So basically, but the vast majority of people who are taking them are non-diabetics.

They're using it for weight loss.

And then, of course, they're on the open market and they're incredibly expensive.

And I'll give you the figures again.

It costs $1,300 a month.

to take Ozempic if you don't have diabetes insurance, right?

That's $15,000 a year.

Now, most poor people don't have that.

So what's going to happen is that the people who are going to actually avail of this are pretty well off.

So it's going to reinforce and double down on the socioeconomic...

impact of being overweight.